| Product Code: ETC7633526 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Lumasiran Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Lumasiran Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Lumasiran Market - Industry Life Cycle |
3.4 Ireland Lumasiran Market - Porter's Five Forces |
3.5 Ireland Lumasiran Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Ireland Lumasiran Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Ireland Lumasiran Market Revenues & Volume Share, By Dosage form, 2021 & 2031F |
3.8 Ireland Lumasiran Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Ireland Lumasiran Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 Ireland Lumasiran Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Ireland Lumasiran Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and adoption of gene-silencing therapies in Ireland |
4.2.2 Rising prevalence of rare genetic diseases that can be treated with lumasiran |
4.2.3 Supportive government policies and initiatives to improve access to advanced medical treatments |
4.3 Market Restraints |
4.3.1 High cost associated with lumasiran treatment may limit affordability for some patients |
4.3.2 Limited availability of healthcare professionals with expertise in administering gene-silencing therapies |
4.3.3 Stringent regulatory requirements and approval processes for gene therapies in Ireland |
5 Ireland Lumasiran Market Trends |
6 Ireland Lumasiran Market, By Types |
6.1 Ireland Lumasiran Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Ireland Lumasiran Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Ireland Lumasiran Market Revenues & Volume, By Miscellaneous Metabolic Agents, 2021- 2031F |
6.1.4 Ireland Lumasiran Market Revenues & Volume, By others, 2021- 2031F |
6.2 Ireland Lumasiran Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Ireland Lumasiran Market Revenues & Volume, By Primary Hyperoxaluria, 2021- 2031F |
6.2.3 Ireland Lumasiran Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Ireland Lumasiran Market, By Dosage form |
6.3.1 Overview and Analysis |
6.3.2 Ireland Lumasiran Market Revenues & Volume, By Injection, 2021- 2031F |
6.3.3 Ireland Lumasiran Market Revenues & Volume, By Solution, 2021- 2031F |
6.4 Ireland Lumasiran Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Ireland Lumasiran Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.4.3 Ireland Lumasiran Market Revenues & Volume, By Demographic, 2021- 2031F |
6.4.4 Ireland Lumasiran Market Revenues & Volume, By Adult, 2021- 2031F |
6.4.5 Ireland Lumasiran Market Revenues & Volume, By Pediatric, 2021- 2031F |
6.5 Ireland Lumasiran Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 Ireland Lumasiran Market Revenues & Volume, By Clinics, 2021- 2031F |
6.5.3 Ireland Lumasiran Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.4 Ireland Lumasiran Market Revenues & Volume, By Diagnostic center, 2021- 2031F |
6.6 Ireland Lumasiran Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Ireland Lumasiran Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 Ireland Lumasiran Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.4 Ireland Lumasiran Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 Ireland Lumasiran Market Import-Export Trade Statistics |
7.1 Ireland Lumasiran Market Export to Major Countries |
7.2 Ireland Lumasiran Market Imports from Major Countries |
8 Ireland Lumasiran Market Key Performance Indicators |
8.1 Patient enrollment in clinical trials for lumasiran |
8.2 Number of healthcare facilities offering lumasiran treatment |
8.3 Rate of successful treatment outcomes with lumasiran |
8.4 Patient satisfaction and quality of life improvements post-lumasiran treatment |
8.5 Adoption rate of lumasiran as a standard treatment option for eligible patients |
9 Ireland Lumasiran Market - Opportunity Assessment |
9.1 Ireland Lumasiran Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Ireland Lumasiran Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Ireland Lumasiran Market Opportunity Assessment, By Dosage form, 2021 & 2031F |
9.4 Ireland Lumasiran Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Ireland Lumasiran Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.6 Ireland Lumasiran Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Ireland Lumasiran Market - Competitive Landscape |
10.1 Ireland Lumasiran Market Revenue Share, By Companies, 2024 |
10.2 Ireland Lumasiran Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here